Alopexx is a clinical stage biotechnology company developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of a wide range of bacterial, fungal and parasitic microbial infections.
Select Slides.
With Alopexx we were tasked with constructing an appealing and informative investor presentation within the strict paramaters outlined by the associate bankers. We were able to perform under agile conditions and provide Aloplexx with a stunning deck.